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Purpose: To develop diclofenac sodium gel using high molecular weight hydroxypropyl methylcellulose 
(HPMC) and Carbopol 934P for topical and systemic delivery. 
Methods: Diclofenac sodium gel was prepared with HPMC K100M and Carbopol 934P as gelling 
agents. The formulations were examined for pH, spreadability, consistency, viscosity, homogeneity, 
drug content and stability. In vitro drug release was evaluated using Franz diffusion cell. Carrageenan-
induced rat paw oedema model was used for the evaluation of the anti-inflammatory activity of the gels. 
A commercial diclofenac sodium gel product was used as the reference drug. 
Results: Formulations containing glycerin as permeation enhancer gave drug release patterns 
comparable to that of the reference product. The drug content of F2, F5 and F9 was 99.81, 99.75 and 
99.96 %, respectively. Accelerated stability results showed no significant variation in the appearance 
and drug release after storage for 3 months.  
Conclusion: Diclofenac sodium gel containing HPMC K100M and Carbopol 934P exhibited 
pronounced anti-inflammatory activity and could be further developed for topical and systemic delivery.. 
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Drug delivery through the skin has been a 
promising concept for a long time because the 
skin is easy to access, has a large surface area 
with vast exposure to the circulatory and 
lymphatic networks and the route is non-invasive 
[1]. Transdermal delivery is of great importance 
for drugs that may cause systemic side effects, 
e.g., non-steroidal anti-inflammatory drugs 
(NSAIDs) [2].  
 
Diclofenac sodium is an effective NSAID often 
used in the treatment of acute and chronic 
arthritic conditions. It is prescribed for long-term 
treatment of rheumatoid arthritis, osteoarthritis 
and ankylosing spondylitis [3]. There is great 
interest to develop non-oral dosage forms of 
diclofenac sodium to minimize its gastric side 
effects and to provide relatively consistent drug 
levels at the application site for prolonged 
periods [2]. Topical delivery of diclofenac sodium 
using various formulations has been described in 
the literature [4,5]. However, effective permeation 
of the drug through skin is difficult to achieve due 
to its intrinsically poor permeability, though this is 
relatively good compared to other commonly 
used NSAIDs [6]. Skin permeation enhancers 
can improve drug skin penetration [7]. 
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HPMC K100M and Carbopol 934P have been 
used as hydrophilic polymers in the formulation 
of gels for transdermal drug delivery. One of their 
most important characteristics is high swellability, 
which has a significant effect on the release 
kinetics of the incorporated drug [8]. Cellulose 
ethers, especially HPMC K100M, are frequently 
used as the basis for sustained release 
hydrophilic matrix tablets [9]. The overall drug 
release mechanism of HPMC K100M-based 
pharmaceutical devices strongly depend on the 
design (composition and geometry) of the 
particular delivery system. On imbibing water, 
HPMC K100M swells, resulting in dramatic 
changes in the viscous nature of the polymer, 
drug concentration and increased dimension of 
the dosage system. Upon contact with water, the 
incorporated drug dissolves and diffuses out of 
the device. Depending on the chain length and 
degree of substitution of the HPMC type used, 
the polymer itself dissolves more or less rapidly. 
Diffusion, water uptake and erosion are the most 
important rate-controlling mechanisms of 
commercially available controlled release 
products [8]. A series of grades based on the 
molecular fraction of these polymers are used at 
concentrations between 1 and 5 % in topical gel 
formulation.  
 
Carrageenan-induced paw oedema in mice has 
been widely used for the evaluation of anti-
inflammatory activity of drugs [10]. 
The aim of this study was to develop suitable 
topical formulations of diclofenac sodium using 
HPMC K100M and Carbopol 934P as gelling 






Diclofenac sodium was purchased from Yarrow 
Chem. Products, Mumbai, India. HPMC K100M 
was obtained as a gift from Colorcon, Mumbai, 
India. Carbopol 934P was purchased from 
Genuine Chemicals, Mumbai, India. All organic 




The solubility of diclofenac sodium was 
determined using various solvents of different 
polarities including methanol, 95 % ethanol, 
water, glacial acetic acid, ether, chloroform and 
phosphate buffer (pH 6.8). The vials containing 
the solvent and excess diclofenac sodium were 
kept in a shaker for 24 h. It was filtered through 
Whatmann filter paper. The filtrate was analyzed 
by UV spectrophotometry to determe the amount 
of diclofenac sodium. 
Fourier transform-infrared spectroscopy (FT-
IR) study 
 
FT-IR study was used to check compatibility and 
interaction between the drug and the polymers.  
The spectra of pure diclofenac sodium and the 
physical mixture of diclofenac sodium and 
polymer, embedded in KBr discs,.were recorded 
in the range of 4000 cm-1 and 400 cm-1 using IR 
spectroscopy (Shimadzu, IR Affinity- 1).  
 
Preparation of diclofenac sodium gel 
 
For formulations F1, F2 and F3, 1 g of diclofenac 
sodium was dissolved in 15 ml of glycerin with 
the aid of mild heat (solution A). Weighed 
quantity of HPMC K100M was added to 75 ml of 
distilled water and stirred until dissolved (solution 
B). Solutions A and B were mixed thoroughly and 
the final weight made up to 100 g. For 
formulations F4, F5 and F6, 1 g of diclofenac 
sodium was dissolved in 15 ml of glycerin with 
the aid of mild heat (solution A). Weighed 
quantity of Carbapol 934P was added to 75 ml of 
distilled water, stirred until dissolved and then 
neutralized with 10 % NaOH (solution B). 
Solutions A and B were mixed thoroughly and 
the final weight made up to 100 g. For 
formulations F7, F8 and F9, 1 g of diclofenac 
sodium was dissolved in 15 ml of glycerin with 
the aid of mild heat, and methyl paraben and 
propyl paraben added (solution A). Weighed 
quantity of sodium alginate was added to 75 ml 
of distilled water and stirred until dissolved 
(solution B). Solutions A and B were mixed 
thoroughly and the final weight made up to 100 
g. The composition of the formulations is outlined 
in Table 1. 
 
The three different hydrophilic polymers were 
used for study and in each formulation code the 
combination of two polymers were used by 
keeping one of the polymers constant.  The 
different nine formulation of diclofenac sodium 
gel (F1-F9) with their code are listed in table 1. 
The gel were kept in plastic well closed container 
and stored at room temperature until the time of 
analysis. 
 
In vitro evaluation of diclofenac gels [11] 
 
The diclofenac sodium gels were subjected to 
evaluation for the following parameters - pH, 
spreadability, consistency, viscosity, 
homogeneisity [12], drug content, in vitro drug 
release studies, in vivo anti-inflammatory activity 
by carrageenan induced paw oedema and 
accelerated stability studies. 
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Drug (g) HPMC 










water to  (g) 
F1 1 2.0 0.25 q. s. 15 - 100 
F2 1 2.0 0.50 q. s. 15 - 100 
F3 1 2.0 0.75 q. s. 15 - 100 
F4 1 - 0.50 q. s. 15 0.1 100 
F5 1 - 0.50 q. s. 15 0.1 100 
F6 1 - 0.50 q. s. 15 0.1 100 
F7 1 1 - q. s. 15 0.1 100 
F8 1 1.5 - q. s. 15 0.1 100 
F9 1 2.0 - q. s. 15 0.1 100 
 
Determination of pH of gel formulations 
 
The pH of the gel formulations was measured 
with a pH meter (Eutech, Cyberscan) using 1 % 
aqueous solutions of the gels at room 
temperature. 
 
This parameter was determined with a wooden 
block and glass slide apparatus.The gel (approx. 
20 g) was added to the pan and the time for the 
upper slide (movable) to separate completely 
from the fixed was noted. Spreadability was 
calculated formulas in Eq 1. 
 
S = W×L/T ………… (1) 
 
where S = spreadability, W = weight tide to upper 
slide, L = length of glass slide, and T = time 





Measurement of consistency of the gels was 
carried out by dropping a cone attached to a 
holding rod from a fix distance of 10 cm in such 
way that it falls in the centre of a glass cup filled 
with the gel. The penetration by the cone was 
measured from the surface of the gel to the tip of 
the cone inside the gel. The distance traveled  by 




The viscosity of the formulations was determined 
using a Brookfield digital viscometer (model DV-
II, USA) equipped with spindle S27.. The gel 
sample (5 g) was placed in the sample holder of 
the viscometer and allowed to settle for 5 min 
and the viscosity measured a rotating speed of 






All the gels formed were tested for homogeneity 
by visual inspection after the gels have been 
allowed to set in a container. They were tested 





A quantity (100 mg) of the gel was dissolved in 
100 ml of phosphate buffer of pH 6.8. The 
volumetric flask containing gel solution was 
shaken for 2 h on a mechanical shaker to allow 
the drug to dissolve completely. The solution was 
filtered and drug content determined 
spectrophotometrically at 276 nm using 
phosphate buffer (pH 6.8) as blank. 
 
In vitro evaluation of diclofenac sodium 
release 
 
Pretreated skin of albino mice was used in the 
Franz diffusion cell experiment. The receptor 
compartment contained 100 ml of phosphate 
buffer pH 6.8. One gram of the test formulation or 
reference was applied to the skin over an area of 
1.131 cm2 and placed across the donor 
compartment. The donor cell was exposed to 
ambient temperature and covered with parafilm 
to prevent evaporation. The temperature of the 
diffusion medium was maintained at 37 ± 1 oC 
while the buffer solution was stirred continuously 
with a Teflon-coated magnetic bar at 500 rpm. 
Samples (1 ml each) were withdrawn from the 
release medium at 30, 60, 90 and 120 min and 
replaced with an equal volume of fresh buffer 
solution to maintain sink conditions. The samples 
were analyzed spectrophotometrically at 276 nm 
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In vivo evaluation of anti-inflammatory 
activity 
 
Anti-inflammatory activity was evaluated by 
carrageenan-induced rat paw oedema method. 
Male albino rats of Wister strain (150 ‐ 200 g) 
were used after due approval of the Institutional 
Animal Ethical Committee (IAEC) of Institute of 
Pharmaceutical Education, Boradi, India (Reg. 
no. 1301/a/08/CPCSEA). The animals were kept 
in plastic cages with soft bedding (6 per cage) 
under standard condition of light and dark cycles 
and had free access to food (standard pellet diet) 
and tap water. The rats were allowed to 
acclimatize for one week prior to the experiment. 
Food was withdrawn 12 h before and during the 
experiment. 
 
The animals were divided into four groups with 
three animals in each group. The first and 
second groups served as controls receiving 
normal saline and gel base without drug, 
respectively. The third group received diclofenac 
sodium ethosomal gel and the fourth group 
received plain diclofenac gel (commercial). 
Carrageenan solution (1 %w/v in normal saline) 
was used to induce inflammation. The animals 
were placed singly in observation chambers for 
10 minute to minimize any stress-related 
behavioral changes. The thickness (mm) of the 
paw was measured at 0, 1, 2, 3, and 4 h after 
carrageenan administration, using a digital 
vernier caliper (Alex) with a sensitivity of 0.01 
mm. 
 
Accelerated stability studies 
 
All the selected formulations were subjected to 
accelerated stability test over a period of three 
months as per ICH guidelines at a temperature of 
40 ± 2 oC/ and 75 % relative humidity (RH). All 
the formulations were analyzed for changes in 





The results were expressed as mean ± standard 
deviation. The data were analyzed by one way 
analysis of variance (ANOVA) followed by 
Bonferroni’s multiple comparison. A level of 







There were no significant changes in the peak 
pattern of the IR spectra of pure diclofenac 
sodium and of the combined drug/polymer 
mixture (fig 1), which implies that there was no 
interaction between the drug and the polymers. 
 
 
Fig 1: FT-IR spectra of pure diclofenac sodium and 
diclofenac sodium/polymer mixtures 
 
Physical properties of gel 
 
Precipitation occurred in some of the gel batches 
(F1, F3, F4, F6, F7 and F9) of polymer based gel 
containing diclofenac sodium which was probably 
due to incompatibility. Hence, these batches 
were discarded and remaining batches (F2, F5 
and F8) were used in further studies.  
 
The results for pH, spreadability, viscosity, 
consistency, homogeneity and drug content are 
shown in Table 2. Spreadability data indicate that 
the gel is easily spreadable by a small amount of 
shear. Consistency reflects the capacity of the 
gel to get ejected in uniform and desired quantity 
when the tube is squeezed. Consistency in terms 
of distance travelled by the cone was 6 mm. The 
gel formulations were homogeneous in texture 
and fell within a pH range of 6.8 to 7.4 which is 
within the normal skin pH in healthy people. The 
results show that there was no significant 
difference between the viscosities of the gel 
formulations and that of the reference.  
 
Table 2: Properties of some diclofenac sodium gel formulations 
 







Homogeneity Drug Content 
(%) 
F2 7.4 5.6 0.94×10-3 6 Very good 99.81 
F5 6.8 3.8 1.60×10-3 6 Good 99.75 
F9 7.1 3.9 1.70×10-3 6 Good 99.96 
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In vitro diclofenac sodium release 
 
Diclofenac sodium release from the F2 
formulation was comparable with that of the 
reference standard (commercial formulation), as 
Table 3 shows. The pH of F2 and the commercial 
gel was was 6.8. 
 
Table 3:  In vitro release characteristics of diclofenac 
sodium gel 
 
Drug release (%) Time 
(min) 
F2 Ref* 
30 38.54 39.64 
60 64.78 65.86 
90 81.23 82.92 
120 96.87 97.34 
*Reference standard (commercial formulation 
 
In vivo anti-inflammatory activity of 
diclofenac gel 
 
The results of the anti-inflammatory test (Fig 2) 
indicate there was no significant difference 
between the anti-inflammatory activities of the 
test formulations and the reference.  
 
Stability of the gels 
 
The results of the accelerated stability studies 
are shown in Table 4. The appearance of the 
gels remained clear and no significant variation 
in pH was observed after subjecting the 
formulations to stability stress for 3 months. Drug 
content was 96.91, 95.33 and 95.65 % 
formulations F2, F5 and F9, respectively, after the 
3-month period. 
 
Fig 2: Inhibition of rat paw edema by reference 
standard (Std) and test (Gel) formulations 
DISCUSSION 
The aim of this study was to develop suitable 
topical gel formulations of diclofenac sodium gel 
using HPMC K100M and Carbopol 934P as a 
gelling agents and glycerin as permeation 
enhancer. 
 
The apparent viscosity of the test formulations 
was comparable to that of the reference 
standard. Due to the viscous and hydrophilic 
nature of HPMC K100M and Carbopol 934P, the 
complex might have expanded more in water 
than the individual polymers would in water and 
hence the increase in solution viscosity. The use 
of glycerin as permeation enhancers significantly 
increased drug release rate. It is generally 
agreed that in vitro drug release data for topical 
formulation cannot be used to accurately predict 
permeation across the skin, due to the barrier 
properties of stratum corneum which can be  
 
 Table 4: Accelerated stability data for diclofenac sodium gel 
 
Formulation Month Appearance pH Drug content (%) 
0 Clear 7.4 99.81 
1 Clear 7.4 98.27 
2 Clear 7.3 97.54 
F2 
3 Clear 7.3 96.91 
0 Clear 6.8 99.75 
1 Clear 6.8 98.87 
2 Clear 6.7 96.05 
F5 
3 Clear 6.6 95.33 
0 Clear 7.1 99.96 
1 Clear 7.1 97.12 
2 Clear 7.1 96.43 
F9 
3 Clear 7.0 95.65 
0 Clear 6.8 99.90 
1 Clear 6.7 98.70 
2 Clear 6.6 97.20 
Commercial 
gel 
3 Clear 6.5 95.90 
Baviskar et al 




altered by the presence of various permeation 
enhancers in the formulation. 
 
The difference between the anti-inflammatory 
activities of the reference standard and test gels 
after 1 and 2 h was not significant, but after 3 
and 4 h, the test gel exhibited significantly higher 




Diclofenac sodium gels prepared using HPMC 
K100M and Carbopol 934P produced better 
spreadability and consistency as compared to 
carbopol 934P and sodium alginate gel (F5) and 
sodium alginate and HPMC K100M gel (F9) 
formulations and hence should be further 
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